| Dr Mark E Rush, MD | |
|
1600 W Antelope Dr, Layton, UT 84041-1120 | |
| (801) 807-7140 | |
| (801) 807-7090 |
| Full Name | Dr Mark E Rush |
|---|---|
| Gender | Male |
| Speciality | Anesthesiology |
| Experience | 41 Years |
| Location | 1600 W Antelope Dr, Layton, Utah |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1801840806 | NPI | - | NPPES |
| 17083312000001 | Other | UT | BLUE CROSS |
| 73000 | Other | UT | PEHP |
| TPRA07445 | Other | UT | MOLINA |
| QM0000030147 | Other | UT | ALTIUS |
| 107018852101 | Other | UT | SELECTHEALTH |
| 12600 | Other | UT | UUHP |
| 170901 | Other | UT | DMBA |
| Facility Name | Location | Facility Type |
|---|---|---|
| Davis Hospital And Medical Center | Layton, UT | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| North Davis Anesthesiology Llc | 5395793905 | 13 |
News Archive
Adult survivors of preterm births may have a lung capacity that resembles the healthy elderly or casual smokers by the time they reach their early 20s, according to a University of Oregon study.
Cell Therapeutics, Inc. today announced that it has entered into an agreement to sell $21.0 million of shares of its Series 5 Preferred Stock in a registered offering to three institutional investors (collectively, the "Initial Purchasers"). Each share of Series 5 Preferred Stock is convertible at the option of the holder, at any time during its existence, into 2,500 shares of common stock at a conversion price of $0.40 per share of common stock, for a total of 52,500,000 shares of common stock.
A new study by Roosevelt University's Illinois Consortium on Drug Policy shows deaths from heroin overdoses in Chicago's Cook County fell 16 percent during the last decade, but the Chicago metropolitan region still ranks among the worst in the nation for heroin use. Kimberly Dennis, M.D., eating disorder specialist at Chicago's Timberline Knolls Residential Treatment Center, sees the use of heroin regularly from women and girls she treats and knows the importance of awareness and seeking help to overcome this addiction.
An in-depth study on the regulation of adenosine-to-inosine (A-to-I) RNA editing by researchers from the Cancer Science Institute of Singapore at the National University of Singapore found that a protein, known as DHX9, acts as a bidirectional regulator of the molecular process which is linked to various types of cancer such as esophageal cancer.
› Verified 8 days ago
| Entity Name | North Davis Anesthesiology Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1679525901 PECOS PAC ID: 5395793905 Enrollment ID: O20050111000311 |
News Archive
Adult survivors of preterm births may have a lung capacity that resembles the healthy elderly or casual smokers by the time they reach their early 20s, according to a University of Oregon study.
Cell Therapeutics, Inc. today announced that it has entered into an agreement to sell $21.0 million of shares of its Series 5 Preferred Stock in a registered offering to three institutional investors (collectively, the "Initial Purchasers"). Each share of Series 5 Preferred Stock is convertible at the option of the holder, at any time during its existence, into 2,500 shares of common stock at a conversion price of $0.40 per share of common stock, for a total of 52,500,000 shares of common stock.
A new study by Roosevelt University's Illinois Consortium on Drug Policy shows deaths from heroin overdoses in Chicago's Cook County fell 16 percent during the last decade, but the Chicago metropolitan region still ranks among the worst in the nation for heroin use. Kimberly Dennis, M.D., eating disorder specialist at Chicago's Timberline Knolls Residential Treatment Center, sees the use of heroin regularly from women and girls she treats and knows the importance of awareness and seeking help to overcome this addiction.
An in-depth study on the regulation of adenosine-to-inosine (A-to-I) RNA editing by researchers from the Cancer Science Institute of Singapore at the National University of Singapore found that a protein, known as DHX9, acts as a bidirectional regulator of the molecular process which is linked to various types of cancer such as esophageal cancer.
› Verified 8 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr Mark E Rush, MD Po Box 160354, Clearfield, UT 84016-0354 Ph: (801) 774-8992 | Dr Mark E Rush, MD 1600 W Antelope Dr, Layton, UT 84041-1120 Ph: (801) 807-7140 |
News Archive
Adult survivors of preterm births may have a lung capacity that resembles the healthy elderly or casual smokers by the time they reach their early 20s, according to a University of Oregon study.
Cell Therapeutics, Inc. today announced that it has entered into an agreement to sell $21.0 million of shares of its Series 5 Preferred Stock in a registered offering to three institutional investors (collectively, the "Initial Purchasers"). Each share of Series 5 Preferred Stock is convertible at the option of the holder, at any time during its existence, into 2,500 shares of common stock at a conversion price of $0.40 per share of common stock, for a total of 52,500,000 shares of common stock.
A new study by Roosevelt University's Illinois Consortium on Drug Policy shows deaths from heroin overdoses in Chicago's Cook County fell 16 percent during the last decade, but the Chicago metropolitan region still ranks among the worst in the nation for heroin use. Kimberly Dennis, M.D., eating disorder specialist at Chicago's Timberline Knolls Residential Treatment Center, sees the use of heroin regularly from women and girls she treats and knows the importance of awareness and seeking help to overcome this addiction.
An in-depth study on the regulation of adenosine-to-inosine (A-to-I) RNA editing by researchers from the Cancer Science Institute of Singapore at the National University of Singapore found that a protein, known as DHX9, acts as a bidirectional regulator of the molecular process which is linked to various types of cancer such as esophageal cancer.
› Verified 8 days ago
Dr. Brian Clint Hales, M.D. Anesthesiology Medicare: Accepting Medicare Assignments Practice Location: 1600 W Antelope Dr, Layton, UT 84041 Phone: 801-774-7140 | |
Mark Robert Gillis, MD Anesthesiology Medicare: Accepting Medicare Assignments Practice Location: 1600 W Antelope Dr, Layton, UT 84041 Phone: 801-807-1000 | |
Dr. Nathan J Hess, D.O. Anesthesiology Medicare: Accepting Medicare Assignments Practice Location: 1600 W Antelope Dr, Layton, UT 84041 Phone: 801-807-1000 | |
Dr. Ryan B Springer, D.O. Anesthesiology Medicare: Accepting Medicare Assignments Practice Location: 1600 W Antelope Dr, Layton, UT 84041 Phone: 602-332-5728 | |
Dr. Clark E Petersen, M.D. Anesthesiology Medicare: Accepting Medicare Assignments Practice Location: 1544 W Antelope Dr, Layton, UT 84041 Phone: 801-773-3339 Fax: 801-773-6727 | |
Joshua M Shepherd, DO Anesthesiology Medicare: Accepting Medicare Assignments Practice Location: 2121 N 1700 W, Layton, UT 84041 Phone: 801-773-4040 | |
Bryan Holbrook, M.D. Anesthesiology Medicare: Medicare Enrolled Practice Location: 1544 W Antelope Dr, Layton, UT 84041 Phone: 801-773-3339 |